Anticoagulation in cirrhosis: from stroke prevention to disease modification?: Editorial on “Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study”
Clinical and Molecular Hepatology · 06.11.2026
DOI: 10.3350/cmh.2026.1061 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Jae Hyun Yoon.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yoon, J. H. (2026). Anticoagulation in cirrhosis: from stroke prevention to disease modification?: Editorial on “Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.1061
Vancouver
Yoon JH. Anticoagulation in cirrhosis: from stroke prevention to disease modification?: Editorial on “Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.1061
BibTeX
@article{Yoon2026,
author = {Yoon, Jae Hyun},
title = {Anticoagulation in cirrhosis: from stroke prevention to disease modification?: Editorial on “Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study”},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.1061}
}
EUVIMED